Press Releases

Sep 2, 2026

Caleb Monroe

Press Releases

SOLOWIN HOLDINGS (AXG)’s AlloyX HK and EvolveQ Signed Strategic MOU to Integrate AI and Quantum Computing for Next-Generation Financial Infrastructure

SOLOWIN HOLDINGS (Nasdaq: AXG) announced that its subsidiary AlloyX HK has signed a strategic non-binding MOU with EvolveQ to explore the integration of AI, quantum computing, and high-performance computing in finance and digital assets. The collaboration aims to develop next-generation AI wealth management platforms, enhance AI infrastructure, and…

AXG

Sep 2, 2026

Caleb Monroe

Press Releases

Shattuck Labs Announces Participation in Upcoming September Investor Conferences

Shattuck Labs, a clinical-stage biotech company focused on developing monoclonal and bispecific DR3 blocking antibodies for inflammatory and immune diseases, announced that management will participate in the Wells Fargo 21st Annual Healthcare Conference and the Cantor Global Healthcare Conference in September 2026. The presentations will include fi…

STTK

Sep 2, 2026

Marcus Reed

Press Releases

PowerCompute to Participate in H.C. Wainwright 28th Annual Global Investment Conference

PowerCompute, a Nasdaq-listed Bitcoin treasury and mining company expanding into high-performance computing (HPC) and artificial intelligence (AI) infrastructure, will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The company highlighted its Verified status on the Vast.ai compute marketplace and recent acquisition of …

PWCM

Sep 2, 2026

Leila Farooq

Press Releases

Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference

Elutia Inc., a Nasdaq-listed company specializing in drug-eluting biomatrix technologies, announced its participation in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company’s leadership will present their technology developments focused on addressing p…

ELUT

Sep 2, 2026

Ajmal Hussain

Press Releases

Netskope Announces Strong Second Quarter Fiscal 2027 Financial Results

Netskope, Inc. announced its Q2 fiscal 2027 financial results showing a 27% year-over-year increase in annual recurring revenue to $899 million and 29% revenue growth to $221 million. The company exceeded guidance across all key metrics driven by innovation and strong customer demand for its Netskope One platform, including early traction in AI sec…

NTSK

Sep 2, 2026

Hana Yamamoto

Press Releases

Appian CFO to Present at Citi’s Global TMT Conference

Appian announced that its CFO, Serge Tanjga, will present at Citi's Global TMT Conference in New York, delivering a live webcasted fireside chat focusing on the company's AI automation platform for enterprise business processes. The presentation highlights Appian's ongoing commitment to AI-powered process automation for large organizations.

APPN

Sep 2, 2026

Derek Hwang

Press Releases

SPS Commerce to Present at Citi's 2026 Global TMT Conference

SPS Commerce, a leading intelligent supply chain network company, announced its management will present at Citi's 2026 Global TMT Conference. The presentation underscores SPS Commerce's role in connecting trading partners globally through AI-powered solutions to optimize supply chain operations.

SPSC

Sep 2, 2026

Avery Klein

Press Releases

Amwell® to participate in upcoming investor conferences

Amwell (NYSE: AMWL), a leader in technology-enabled healthcare platforms, announced that its CFO and COO Mark Hirschhorn will represent the company at two prestigious investor conferences in September 2026. These events include the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference, where t…

AMWL

Sep 2, 2026

Leila Farooq

Press Releases

Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Scribe Therapeutics reported second-quarter 2026 financial results alongside key corporate milestones including the initiation of the first-in-human Phase 1 trial for STX-1150, a novel CRISPR-based LDL-C lowering therapy. The company secured over $25 million from the California Institute for Regenerative Medicine to advance cardiometabolic gene-edi…

SCTX

Sep 2, 2026

Jordan Park

Press Releases

Gold.com Reports Fiscal Fourth Quarter and Full Year 2026 Results

Gold.com, a leading integrated alternative assets platform specializing in precious metals and collectibles, reported robust fiscal fourth quarter and full year 2026 financial results. The company achieved significant revenue growth driven by organic expansion, strategic acquisitions including Sunshine Minting, and increased sales volume. Net incom…

GOLD

Sep 2, 2026

Leila Farooq

Press Releases

Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients

Nyxoah announced that its ACCCESS U.S. pivotal study for the Genio system successfully met primary safety and efficacy endpoints in patients with Complete Concentric Collapse (CCC) obstructive sleep apnea (OSA). The study reported a 77.2% Apnea-Hypopnea Index (AHI) responder rate and zero device-related serious adverse events over 12 months. The re…

NYXH

Sep 2, 2026

Priya Menon

Press Releases

Matrix Service Company Reports Fiscal Year 2026 Fourth Quarter and Full-Year Results

Matrix Service Company announced Q4 fiscal 2026 revenue growth to $244.5 million, the highest quarterly revenue in six years, with a net income of $1.1 million compared to a loss in the prior year. The company achieved adjusted net income for the second consecutive profitable quarter and ended the fiscal year with liquidity of $283.9 million and no…

MTRX

Sep 2, 2026

Leila Farooq

Press Releases

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

Kymera Therapeutics, a clinical-stage biopharmaceutical company specializing in targeted protein degradation for immunological diseases, announced its participation in several upcoming investor conferences throughout September 2026. The company will present and participate in fireside chats at major events hosted by Wells Fargo, Citi, H.C. Wainwrig…

KYMR

Sep 2, 2026

Maya Rios

Press Releases

Aura Biosciences to Participate in Upcoming Investor Conference

Aura Biosciences, a clinical-stage biotechnology company focused on developing a novel therapy for ocular cancers, announced its CEO, Natalie Holles, will participate in the Morgan Stanley 24th Annual Global Healthcare Conference. The company highlighted its Phase 3 fully enrolled trial for bel-sar in early choroidal melanoma and ongoing studies in…

AURA

Sep 2, 2026

Priya Menon

Press Releases

Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Black Diamond Therapeutics announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference, with a presentation and one-on-one investor meetings scheduled. The company highlighted advancements in its investigational EGFR inhibitor, silevertinib, targeting oncology indications such as EGFR-mutant non-small cell lung cance…

BDTX

Sep 2, 2026

Leila Farooq

Press Releases

Duolingo to Participate in Citi’s 2026 Global TMT Conference

Duolingo announced that CEO Luis von Ahn will participate in a fireside chat at the Citi 2026 Global TMT Conference. The event will be webcast live and later available for replay. Duolingo is recognized as the leading mobile language learning platform globally, known for its highly popular app and commitment to quality and accessibility in educatio…

DUOL

Sep 2, 2026

Priya Menon

Press Releases

Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Spero Therapeutics, a clinical-stage biopharmaceutical company specializing in immunology and inflammation, announced that its CEO, Esther Rajavelu, will present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover the company’s pipeline with a focus on its lead program, SP001, targeting immune-media…

SPRO

Sep 2, 2026

Marcus Reed

Press Releases

Oxford Lane Capital Corp. Announces Partial Redemption of 5.00% Notes Due 2027

Oxford Lane Capital Corp., a closed-end management investment company focusing on CLO debt and equity tranches, announced it will redeem $30 million aggregate principal amount of its 5.00% Notes due 2027 at $25 per Note plus accrued interest, with redemption effective October 2, 2026. The Notes trade on Nasdaq under ticker OXLCZ.

OXLCZ

Sep 2, 2026

Sofia Navarro

Press Releases

Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome

Ultragenyx Pharmaceutical announced that its Phase 3 Aspire clinical trial of apazunersen (GTX-102) for Angelman syndrome did not meet the primary or key secondary efficacy endpoints. Despite a consistent safety profile, the company expressed disappointment and will evaluate the future of the program while planning to implement significant expense …

RARE

Sep 2, 2026

Nina Shah

Press Releases

Five Below, Inc. Announces Second Quarter Fiscal 2026 Financial Results

Five Below, Inc. delivered solid financial results for Q2 FY 2026, with net sales increasing 22.9% to $1.26 billion and comparable sales up 14.1%. Operating income surged significantly, and diluted EPS increased to $3.99 from $0.77 year-over-year. The company opened 52 net new stores this quarter, totaling 2,022 stores nationwide. With strong momen…

FIVE

Sep 2, 2026

Nina Shah

Press Releases

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company focused on novel Alzheimer's therapeutics, will participate in upcoming investor conferences to discuss progress and developments. The company is advancing its lead drug candidate, sabirnetug, in Phase 2 trials and exploring innovative delivery technologies.

ABOS

Sep 2, 2026

Nina Shah

Press Releases

Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company focused on CNS diseases, announced that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its outstanding Form 10-Q reports for the second and third quarters of 2026. Consequently, its common stock will continue trading on the Nasdaq Global Select Marke…

AVXL

Sep 2, 2026

Caleb Monroe

Press Releases

Cytokinetics to Participate in September Investor Conferences

Cytokinetics, a specialty cardiovascular biopharmaceutical company, announced that members of its management team will participate in multiple investor conferences in September 2026, including Citi, Cantor, Morgan Stanley, and Bernstein events. The company will discuss progress on its cardiac myosin inhibitors and activators, including the approved…

CYTK

Sep 2, 2026

Jordan Park

Press Releases

Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Arcutis Biotherapeutics, a commercial-stage biopharmaceutical company focusing on immuno-dermatology, announced that its management will present at the Morgan Stanley 24th Annual Global Healthcare Conference in September 2026. The presentation will provide insights into the company's progress and strategies. The company also reaffirmed its commitme…

ARQT

Sep 2, 2026

Nina Shah

Press Releases

New Model Home Opens at Toll Brothers at the Crossing at Coal Mountain in Cumming, Georgia

Toll Brothers, a leading luxury homebuilder, has opened a new model home at their master-planned community, The Crossing at Coal Mountain in Cumming, GA. The Oakridge Elite with Loft, part of the Haven Collection, showcases spacious, modern design with upscale features and is priced from the low $500,000s. This launch highlights Toll Brothers' comm…

TOL